Ostrum Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35M | Sell |
8,274
-360
| -4% | -$146K | 0.16% | 115 |
|
|
2025
Q1 | $4.3M | Buy |
8,634
+444
| +5% | +$221K | 0.23% | 79 |
|
|
2024
Q4 | $4.26M | Buy |
8,190
+1,285
| +19% | +$668K | 0.37% | 58 |
|
|
2024
Q3 | $4.27M | Sell |
6,905
-4,254
| -38% | -$2.63M | 0.35% | 58 |
|
|
2024
Q2 | $6.17M | Sell |
11,159
-1,093
| -9% | -$604K | 0.54% | 29 |
|
|
2024
Q1 | $7.12M | Sell |
12,252
-221
| -2% | -$128K | 0.56% | 22 |
|
|
2023
Q4 | $6.62M | Sell |
12,473
-3,996
| -24% | -$2.12M | 0.58% | 25 |
|
|
2023
Q3 | $8.34M | Sell |
16,469
-790
| -5% | -$400K | 0.77% | 10 |
|
|
2023
Q2 | $9M | Buy |
17,259
+585
| +4% | +$305K | 0.75% | 8 |
|
|
2023
Q1 | $9.61M | Buy |
+16,674
| New | +$9.61M | 0.84% | 7 |
|
|
2019
Q3 | – | Sell |
-23,250
| Closed | -$6.83M | – | 129 |
|
|
2019
Q2 | $6.83M | Buy |
23,250
+6,810
| +41% | +$2M | 1.89% | 12 |
|
|
2019
Q1 | $4.5M | Buy |
16,440
+1,990
| +14% | +$545K | 1.47% | 14 |
|
|
2018
Q4 | $3.23M | Buy |
+14,450
| New | +$3.23M | 1.27% | 14 |
|